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ABSTRACT
The solid complexes of gliclazide and β-cyclodextrin were prepared by 2 methods, liquid/liquid extraction and neutralization. The phase-solubility diagram was used to calculate the stability constant of gliclazide and β-cyclodextrin. According to the
molar stoichiometry, the complex of gliclazide with β-cyclodextrin was prepared following the 1:1 ratio. The interaction between
gliclazide and β-cyclodextrin was analyzed by Fourier-transform infrared spectroscopy and differential scanning calorimetry. The
dissolution rate of gliclazide from the complex made by liquid/liquid extraction was faster than those from neutralization method,
physical mixtures and pure drug. The mean particle size of two complexes was smaller with a narrower size distribution than
those of physical mixtures and β-cyclodextrin. The results indicate that liquid/liquid extraction method, as well as neutralization
method, provides some signs of improvement in the solubility and dissolution rate of gliclazide.
Key words: Gliclazide, Cyclodextrin, Liquid/liquid extraction, Neutralization, Solubility

INTRODUCTION
The application of complexation in different drugs
with cyclodextrins (CDs) has been extensively studied in
recent years to improve specific characteristics of pharmaceutical interest, such as solubility in aqueous media,
dissolution rate (1-3), chemical stability (4), and bioavailability (5-6). Six to eight glucose units linked by a-1,4glucosidic bonds compose the cyclic oligosaccharides
known as CDs. CDs that have a large internal axial cavity
are crystalline and nonhygroscopic with cylinder-shaped
and macro ring structure. The internal cavity of a CD
molecule is hydrophobic, while its outer surface is hydrophilic (7-8). Occupying the cavity of CDs molecule by
either the whole or partial drug molecule, CDs are able to
form the inclusion complexes with many drugs(9).
As a second generation of sulfonylurea, Gliclazide
[GL; 1-(1-azabicyclo(3,3,0) octyl)-3-(p-tolylsulfonylurea)]
is widely used in the treatment of non-insulin dependent
diabetes mellitus (NIDDM). Due to its short-term acting,
GL has been considered suitable for diabetic patients
with renal impairment and for elderly patients that have
reduced renal function and follow a sulphonylureas treatment which may increase the risk of hypoglycemia (10).
This GL molecule is characterized by low solubility in
gastric f luids, low dissolution rate and interindividual
variability in its bioavailability(11).
The present study was to investigate the inclusion
mode between GL and β-CD in the solid state using differ* Author for correspondence. Tel:+886-7-3121101 ext. 2254;
Fax:+886-7-3210683; E-mail:chamtm@kmu.edu.tw

ential scanning calorimetry (DSC) and Fourier-transform
infrared spectroscopy (FTIR). Physical mixing, neutralization and liquid/liquid extraction method were used for
the preparation of inclusion complex. The dissolution
rate and the solubility of two solid complexes were also
evaluated. The employment of liquid/liquid extraction in
preparing this complex has not yet been reported (12-15),
and the method has an advantage of reduced preparation
time. The primary purpose of this study was to compare
the dissolution rate and the solubility between these two
complexes prepared by neutralization and liquid/liquid
extraction method. The results suggest that a transformation of GL into a salt form or nanoparticle may be
employed to increase its solubility and enhance its dissolution rate as well.

MATERIALS AND METHODS
I. Materials
GL was a gift from Lotus Pharmaceutical Co., Ltd.
(Taipei, Taiwan). β-CD was purchased from Roquette
Fréres (Lestrem, France). Tolbutamide was purchased
from Sigma Chemical Co. (Louis, USA). All other materials were of either reagent or analytical grade.
II. Phase-solubility Assays
Phase-solubility studies were employed to determine the ratio of complexation of GL and β-CD. Excess
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amounts of GL were added to 10 mL of deionized water
containing various concentrations of β-CD (0.005 to 0.1 M).
The suspensions were shaken at 25±1°C for 3 consecutive days. After equilibrium was attained, the samples
were filtered with a 0.45 μm membrane filter and assayed
by HPLC method. According to the following formula
proposed by Higuchi and Connors (16), the apparent 1:1
ratio stability constant (Ks) was calculated by the linear
regression analysis method (Y = Slope X + Intercept) from
the initial upright portion of the phase-solubility diagram.
Ks =

Slope
Intercept × (1–Slope)

(1)

III. Analysis of the Precision and Accuracy of GL
The precision and accuracy of GL were assayed using
a HPLC method, which includes Waters 2690D separations module (Milford, USA) and Supelco Discovery ®
C18 column (5 μm, 250 × 4.6 mm I.D.) (Bellefonte, USA).
The mobile phase consisted of methanol/water (65:35 v/v)
adjusted to pH 3.0 with phosphoric acid at the flow rate of
1.0 mL/min. A 20 μL sample and tolbutamide as internal
standard were injected together and absorbed at 225 nm
with Waters 2996 photodiode array detector.
Fresh standard GL solutions for preparation of calibration curve was measured at 8:00 am, 10:00 am, 12:00 pm,
2:00 pm, 4:00 pm and 6:00 pm for six consecutive days.
The average, standard deviation, variation and relative
difference of GL contents were calculated to evaluate the
stability of analytic condition, as well as the precision and
the recurrence of measured data.

occurred. After clarification by continually stirring in
β-CD, the mixing solution blended with 25 mL of ethyl
acetate was poured into the separatory funnels. The phase
of ethyl acetate was collected after the mixing solution
was shaken for about 2 min. This extraction was repeated
four times and the collected aqueous phase was evaporated at 40°C until the solid complex was obtained.
V. DSC Thermogram Studies
DSC scans of GL, β-CD, physical mixture and two
solid complexes were recorded on a Perkin-Elmer model
DSC 7 (Norwalk, USA). The instrument was calibrated
with indium and zinc prior to analyzing the samples
under nitrogen at the flow rate of 20 mL/min. 4 mg of
each sample was scanned in sealed aluminum pans at the
heating rate of 20°C/min over the temperature range of
50-250°C.
VI. FTIR Spectroscopic Studies
The FTIR spectra were performed on Perkin-Elmer
spectrum System 2000 FTIR spectrometer (Norwalk,
USA). GL, β - CD, physical mixt u re and t wo solid
complexes were prepared by the KBr disc method and
scanned at the resolution of 4 cm-1 over the wavenumber
region 4000-400 cm-1. Air was used as the background
and the data were averaged from 10 scans.
VII. Dissolution Test

Accurately weighed, GL and β-CD were passed
through 40 meshes and blended in a mortar for 10 min.

According to the USP 24 paddle apparatus, in vitro
dissolution tests were performed with Hanson SR8 Plus
(Chatsworth, USA). Four Samples containing 80 mg of
GL, equivalent amount of two inclusion complexes and
a physical mixture were poured separately into 900 mL
of deionized water at 37 ± 0.5°C with stirring rate at 100
rpm. Afterwards, 0.2 mL of each sample was withdrawn
respectively at 1, 3, 5, 10, 15, 30, 60 and 120 min by the
Waters transfer module (Milford, USA). Subsequently,
the concentration of the samples was assayed using the
HPLC method.

(II) Neutralization Method

VIII. Particle Size Measurement

GL was weighed and poured into 50 mL of 1 N
sodium hydroxide solution, and then β-CD was added and
stirred until a clear solution was obtained. 50 mL of 1 N
hydrochloric acid was dripped into the solution and stirred
for 2 hours. The formed precipitate was separated by
vacuum filtration and washed repeatedly for three times
by cool alcohol and then dried at room temperature(12-15).

Laser diffraction was used to measure the particle
sizes of GL, β-CD, physical mixt ure and two solid
complexes. The measurements were performed with a
particle size analyzer Beckman Coulter LS230 (Miami,
USA). Prior to measurements, about 50 mg of each
sample were diluted with 100 mL of ethylene glycol. The
five particle size distributions were estimated by setting
the intensity of the scattered light at λ=750 nm and the
scattering angle at θ=0.017-34°. The background medium
was ethylene glycol (η=16.1 mPa·s) and refractive index
was 1.431.

IV. Preparation of Solid Complex
Based on the results of the phase-solubility studies,
the complexes were prepared in 1:1 GL:β-CD molar ratio.
(I) Preparation of the Physical Mixture

(III) Liquid/Liquid Extraction Method
GL was added to 50 mL of 1 N sodium hydroxide solution and stirred until a homogeneous solution
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RESULTS AND DISCUSSION

II. Validation of Quantification Method

I. Phase-solubility Studies
The phase-solubility diagram obtained for GL-βCD
is represented in Figure 1. The shape of the solubility
diagram followed a Bs type system(16), and the solubility of
GL was 1.67×10 -4 M which was similar to that of the previous reports (15). The initial solubility of GL was rapidly
raised as the concentration of β-CD increased (Figure 1(a)).
When β-CD was continually increased, the solubility of GL
remained unchanged (see the short plateau on Figure 1(b)).
Instantaneously, the solubility of GL was decreasing along
with the augmentation of β-CD (Figure 1(c)). According
to eq 1, the calculation of the stability constant (Ks) was
155.2 M-1. The slope of eq 1 was calculated by the linear
regression analysis method (Y = 2.53×10 -2 X + 2×10 -4)
from the initial upright portion of the solubility diagram
(Figure 1(a)). We found that our stability constant (Ks)
was obviously different from other previous reports(13-16),
perhaps due to shorter shaking time or different sources of
materials. In short, the phase solubility study suggested
the formation of GL-βCD inclusion complex with 1:1 molar
ratio, and the equimolecular GL-βCD was then prepared for
the next complexation step.

Calibration curve of GL, Y = 0.0243 X - 0.031 (r =
0.9999), showed the excellent linear relationship with
concentration ranged between 10.0 and 100.0 μg/mL.
Precision and accuracy of chromatography are listed in
Table 1. The lowest measurable concentration was 10.0
μg/mL and C.V.% was from 0.21 to 4.09, so the result was
sufficiently acceptable.
III. Evidence of GL-βCD Complexation
(I) DSC Thermogram Studies
For drugs that form inclusion complexes with CDs,
DSC is a fast and relatively inexpensive technique to
examine the absence of the drug melting endotherm in
order to verify if the drug is successfully complexed (17).
The results of DSC thermogram for five samples are
shown in Figure 2. The DSC curve of GL showed an
endothermic reaction and its melting peak was at the
onset temperature of 175°C. The thermal behavior of
β-CD exhibited a slight upward curve at 115°C; however, it was an amorphous reaction. Corresponding to
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Figure 1. Phase solubility diagram of the GL-βCD system in water
at 25°C.
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Figure 2. DSC curves of (1) GL, (2) β-CD, (3) physical mixture, (4)
neutralization solid complex, and (5) liquid/liquid extraction solid
complex.

Table 1. Intra-day and Inter-day analytical precision and accuracy of GL determination
Intra-day (n = 6)
Concentration (μg/mL)

Accuracy
R.E.(%)

Precision
Mean ± S.D. (C.V.%)

Accuracy
R.E.(%)

9.98 ± 0.36 (3.61)

-0.20

10.03 ± 0.41 (4.09)

0.30

20.00

19.92 ± 0.31 (1.56)

-0.40

20.05 ± 0.37 (1.85)

0.25

40.00

40.12 ± 0.22 (0.55)

0.30

40.26 ± 0.29 (0.72)

0.65

80.00

80.19 ± 0.18 (0.22)

0.24

81.05 ± 0.31 (0.38)

1.31

100.00

100.58 ± 0.21 (0.21)

0.58

101.02 ± 0.28 (0.28)

1.02

10.00

Precision
Mean ± S.D. (C.V.%)

Inter-day (n = 6)
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Table 2. Comparison of FTIR spectra from GL, physical mixture and solid complexes from neutralization and liquid/liquid extraction
Solid complexes

GL (cm-1)

physical
mixture (cm-1)

1164

1162

1350

1352

1709

1710

3272

3272

3375

Neutralization
(cm-1)

Liquid/liquid
extraction (cm-1)

Comment

1156

1156

Change in S=O symmetric stretching

1335

1335

Change in S=O antisymmetric stretching

1725

1725

Carbonyl/hydroxyl interaction

3375

Amino/hydroxyl interaction

100

(1)
3272

1709

liquid/liquid extraction
neutralization
physical mixture
gliclazide

1350
1164

%T

(2)
(3)
1710

1725

(4)

1335
1156

3375
1725

(5)

60

40
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Figure 3. FTIR spectra of (1) GL, (2) β-CD, (3) physical mixture,
(4) neutralization solid complex, and (5) liquid/liquid extraction
solid complex.

Figure 4. The dissolution profiles of liquid/liquid extraction solid
complex (●), neutralization solid complex (▲), physical mixture (■),
and GL (♦).

GL melting, the thermogram of the physical mixture
revealed an evident peak at 175°C. Furthermore, the
cur ve of physical mixture showed a similar upward
phenomenon as the one of β-CD. Nevertheless, this peak
shifted from 115 to 145°C due to the interaction of β-CD
and GL.
From the thermogram, we found that two inclusion complexes from neutralization and liquid/liquid
extraction had different reactions. First of all, the solid
complex of neutralization showed a very small melting
peak at the temperature of 175°C, which may be caused
by remains of GL. Secondly, the thermal behavior of the
solid complex from liquid/liquid extraction demonstrated
no reaction from any temperature intervals that could be
attributed to the molecule of GL entering into the β-CD
cavity. The absence of the DSC thermogram for this
solid complex can also be suspected for its amorphous
character. Eventually, the thermogram of amorphous
GL-βCD from liquid/liquid extraction reveals its endotherm characters that come from the dehydration of β-CD
and the loss of the endothermic melting peak found in
the crystalline GL. This also indicates that GL is well
dispersed into the β-CD cavity and its recrystallization
is restrained (18).

(II) FTIR Spectroscopy Studies
FTIR spectra were employed to confirm the complexation of GL/β-CD from liquid/liquid extraction and
neutralization. The spectra of two complexes were also
compared with GL, β-CD and the physical mixture (Figure
3 and Table 2).
Accordingly, the spectrum of GL for carbonyl group
showed a sharp concave curve at 1709 cm-1. Both inclusion complex bands, however, were broader with less
frequency and shifted from 1709 to 1725 cm -1. This
reaction seems to result from the interaction between the
hydroxyl groups of β-CD and the carbonyl groups of GL
that is in good agreement with published researches(13,19).
For the sulphonyl group bands, the spectra of GL
are characterized by a symmetric stretching peak at 1164
cm-1 and an antisymmetric stretching peak at 1350 cm-1.
The symmetric vibration peak of two inclusion complexes
presented less frequency and shifted from 1164 to 1156
cm-1, whereas the antisymmetric vibration peak performed
the same frequency reduction and shifted from 1350 to 1335
cm-1. Based on the previous reports, the reasons for this
phenomenon might be the interaction between the oxygen
atoms of GL and the hydrogen atoms of β-CD(13,19).
For the amino group, GL demonstrated an evident
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Table 3. Mean size and volume of particle of GL, β-CD, physical mixture, and 2 solid complexes from neutralization and liquid/liquid
extraction (n = 3)
Materials

Mean size ± S.D. (μm)

GL

47.56 ± 2.11

Volume of particle ± S.D. (%)
5-50 μm

10-100 μm

40-400 μm

100-1000 μm

61.0 ± 1.4

90.6 ± 2.2

52.6 ± 1.2

4.62 ± 2.8

β-CD

160.04 ± 3.42

16.1 ± 2.3

41.4 ± 1.8

82.4 ± 1.2

57.2 ± 1.1

Physical mixture

145.1 ± 5.81

15.0 ± 2.2

31.1 ± 1.6

86.9 ± 1.3

67.0 ± 1.4

Neutralization

68.29 ± 2.76

53.4 ± 1.9

50.3 ± 2.0

28.7 ± 1.8

37.0 ± 1.6

Liquid/liquid extraction

48.38 ± 2.08

80.3 ± 1.1

74.7 ± 1.7

18.8 ± 2.3

13.7 ± 2.5

IV. Dissolution Behavior of GL-βCD
The dissolution profiles of GL, physical mixture and
the two solid complexes from liquid/liquid extraction and
neutralization are shown in Figure 4. The dissolution
rates for two solid complexes were greater than physical
mixtures and GL alone. The initial dissolution rate of GL
was very slow with only about 5% of the drug dissolved in
30 min. The dissolution rates in this study were different
from previous reports(12-13), which could be caused by the
variation of dissolution condition and materials.
The complexation of GL with β-CD in FTIR analysis
indicated that two solid complexes were well formed. The
formation of these two solid complexes would increase the
drug wettability and then enhanced its dissolution rates as
well. We also found that the improvement of the dissolution rate was related to the preparation method, since the
liquid/liquid extraction method exhibits the highest dissolution rates than the other solid complex.
V. Variation of Particle Size
The mean particle size of GL, β-CD, physical mixture
and two solid complexes are listed in Table 3. We found
that the particle size of β-CD was 160.04 ± 3.42 μm.
However, the particle size of solid complex was 48.38 ±
2.08 μm from liquid/liquid extraction and 68.29 ± 2.76 μm
from neutralization. Because of hydrogen bonding, the
molecules of β-CD was bonded together and formed bigger

Differential Volume

7

β-CD
gliclazide
liquid/liquid extraction
neutralization
physical mixture

6
5

Volume (%)

peak at 3272 cm-1. Nevertheless, a slight curve shifting
from 3272 to 3375 cm -1 appeared on the two inclusion
complexes bands. This phenomenon corresponds with the
previous report as well(13).
On the other hand, the examination of spectra for
the physical mixture showed only straight characters of
two components. Moreover, the band had less frequency
decrease than GL and it had no evident peak shift for
carbonyl group, amino group and sulphonyl group. These
findings were also similar with the previous data(13,19).
In short, the two inclusion complexes prepared from
liquid/liquid extraction and neutralization had no significant characters of GL in the FTIR spectrum, suggesting
these two complexes were well formed.

4
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Figure 5. Particle size distributions of GL (■), β-CD (○), physical
mixture (▬), solid complex from neutralization (●), and solid
complex from liquid/liquid extraction (□).

particle than those in two solid complexes. The particle
size of complex from neutralization was bigger than the
one from liquid/liquid extraction. This phenomenon may
be due to partial uncomplexation of GL and β-CD.
The particle size distributions of GL, β-CD, physical mixture and two solid complexes are shown in Figure
5 and Table 3. Based on 80% of particle appearances of
each sample, four size ranges were chosen and studied
to discover real particle distributions. From the experiment result, 82.4% of β-CD particles were distributed
between 40-400 μm, and 80.3% of solid complex particles
from liquid/liquid extraction were between 5-50 μm. The
solid complex particles from liquid/liquid extraction were
smaller and had much more restricted particle distribution
ranges than those of β-CD. In addition, only 53.4% of
solid complex particles from neutralization were between
5-50 μm, of which 37.0% were between 100-1000 μm.
This result suspected that little β-CD remained from the
complexation of neutralization method. Nevertheless, the
size distributions also showed a growing volume of small
particles and a remarkably decreasing volume of large
particles for two solid complexes. The results indicated
that GL molecule may enter internal cavity of β-CD and
then form a stable solid complex.
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CONCLUSIONS
According to phase-solubility studies, amorphous
GL-βCD solid complexes were prepared at molar ratio 1:1
by liquid/liquid extraction and neutralization methods.
The formation of two solid complexes was confirmed
successful by FTIR analysis and DSC thermograms.
FTIR analysis indicated the interaction of hydrogen bonding between the molecules of GL and β-CD. DSC thermograms demonstrated the absence of GL melting for
amorphous solid complexes from liquid/liquid extraction,
while the convex curve of solid complex from neutralization remained very small.
In regard to this dissolution study, drug releases from
the solid complex by liquid/liquid extraction was faster
than all other samples. The particle size measurement
also found that the smallest particle was from the solid
complex of liquid/liquid extraction. The reasons of this
finding are attributed to the increase of drug wettability,
the reduction of drug particle size and the prevention of
drug aggregation.
The inclusion complex of GL-βCD prepared by
liquid/liquid extraction method with less preparation time
offers another suggestion for immediate released dosage
of insoluble drug used in clinical therapy.
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